Brivaracetam Solution
Product Images NDC 72205-033

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 72205-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brivaracetam-bttle-label (Brivaracetam Bttle Label)

This text appears to provide information about a medication containing 10 mg of brivaracetam per mL. It includes details on dosage, storage instructions, and precautions. The medication is distributed by Novadoz Pharmaceuticals LLC and should be stored at 20°C to 25°C. The medication package includes a Medication Guide that should be dispensed to each patient. It is advised to keep the product out of reach of children and to discard any unused product remaining after 5 months of opening.*

FDA Label Image

Brivaracetam-crtn-label (Brivaracetam Crtn Label)

This is a description of Brivaracetam Oral Solution. It is a medication provided in a 300 mL bottle. The usual dosage should be followed as per the prescribing information. The solution should be stored at 20° to 25°C and should not be frozen. Any unused product after 5 months of opening should be discarded. Pharmacists are instructed to dispense a Medication Guide to each patient. The solution contains 10 mg of Brivaracetam per mL. The product is manufactured by MSN Pharmaceuticals Inc and distributed by Novadoz Pharmaceuticals LLC. The contact information for Novadoz Pharmaceuticals LLC is provided as well.*

FDA Label Image

Fig-1 (Brivaracetam Figure 1)

This text provides information on the proportion of patients and the reduction in seizure frequency from baseline for different dosages of Brivaracetam compared to Placebo. The data is presented in a chart format with the number of patients in each group listed.*

FDA Label Image

Str (Brivaracetam Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.